Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stepped vs Usual Dosage of Efavirenz in HIV
NCT00556634Phase 4Completed
- Sponsor
- Sociedad Andaluza de Enfermedades Infecciosas
- Start
- Apr 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of efavirenz in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by Sociedad Andaluza de Enfermedades Infecciosas. Primary endpoint: Incidence and severity of neuropsychiatric side effects at 4 weeks. Started Apr 2006; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00556634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556634.